Submitted URL: http://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll...
Effective URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Submission: On September 27 via api from IN — Scanned from IT

Summary

This website contacted 11 IPs in 4 countries across 8 domains to perform 115 HTTP transactions. The main IP is 157.185.128.14, located in Paris, France and belongs to ML-1432-54994, CA. The main domain is www.pharmasources.com.
TLS certificate: Issued by TrustAsia RSA OV TLS CA G3 on December 7th 2023. Valid for: a year.
This is the only time www.pharmasources.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 61.147.84.43 137697 (CHINATELE...)
2 2 61.147.84.35 137697 (CHINATELE...)
1 76 157.185.128.14 54994 (ML-1432-5...)
7 172.217.18.8 15169 (GOOGLE)
18 185.232.59.134 135391 (AOFEI-HK ...)
2 111.45.3.198 56040 (CMNET-GUA...)
2 142.250.181.238 15169 (GOOGLE)
2 216.239.36.181 15169 (GOOGLE)
2 142.251.168.157 15169 (GOOGLE)
3 216.58.206.34 15169 (GOOGLE)
1 142.250.186.98 15169 (GOOGLE)
1 142.250.185.100 15169 (GOOGLE)
115 11
Apex Domain
Subdomains
Transfer
94 pharmasources.com
www.pharmasources.com
eimg.pharmasources.com
5 MB
7 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 57
685 KB
6 doubleclick.net
stats.g.doubleclick.net — Cisco Umbrella Rank: 152
td.doubleclick.net — Cisco Umbrella Rank: 216
googleads.g.doubleclick.net — Cisco Umbrella Rank: 53
3 KB
3 google.com
analytics.google.com — Cisco Umbrella Rank: 158
www.google.com — Cisco Umbrella Rank: 3
455 B
2 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 52
22 KB
2 baidu.com
hm.baidu.com — Cisco Umbrella Rank: 10108
12 KB
2 webpower.asia
filter.webpower.asia
995 B
1 b2b-test.com
edm.b2b-test.com
212 B
115 8
Domain Requested by
76 www.pharmasources.com 1 redirects www.pharmasources.com
18 eimg.pharmasources.com www.pharmasources.com
7 www.googletagmanager.com www.pharmasources.com
www.googletagmanager.com
3 td.doubleclick.net www.googletagmanager.com
2 stats.g.doubleclick.net www.googletagmanager.com
2 analytics.google.com www.googletagmanager.com
2 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
2 hm.baidu.com www.pharmasources.com
2 filter.webpower.asia 2 redirects
1 www.google.com www.pharmasources.com
1 googleads.g.doubleclick.net www.googletagmanager.com
1 edm.b2b-test.com 1 redirects
115 12
Subject Issuer Validity Valid
*.pharmasources.com
TrustAsia RSA OV TLS CA G3
2023-12-07 -
2024-12-04
a year crt.sh
*.google-analytics.com
WR2
2024-08-26 -
2024-11-18
3 months crt.sh
baidu.com
GlobalSign RSA OV SSL CA 2018
2024-07-08 -
2025-08-09
a year crt.sh
*.google.com
WR2
2024-08-26 -
2024-11-18
3 months crt.sh
*.g.doubleclick.net
WR2
2024-08-26 -
2024-11-18
3 months crt.sh
*.doubleclick.net
WR2
2024-08-26 -
2024-11-18
3 months crt.sh
www.google.com
WR2
2024-08-26 -
2024-11-18
3 months crt.sh

This page contains 5 frames:

Primary Page: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Frame ID: C476D40234D4C0E03C811DB59C0C073F
Requests: 101 HTTP requests in this frame

Frame: https://td.doubleclick.net/td/ga/rul?tid=G-MVK0C784Q4&gacid=786800441.1727420085&gtm=45je49p0v893253820za200&dma=0&gcd=13l3l3l3l1l1&npa=0&pscdl=noapi&aip=1&fledge=1&frm=0&tag_exp=101671035~101747727&z=1176663135
Frame ID: BC99953E4DA4765C324C7A0DEE8288F3
Requests: 1 HTTP requests in this frame

Frame: https://td.doubleclick.net/td/ga/rul?tid=G-M38VCXVV5K&gacid=786800441.1727420085&gtm=45je49p0v9128801536za200&dma=0&gcd=13l3l3l3l1l1&npa=0&pscdl=noapi&aip=1&fledge=1&frm=0&tag_exp=101671035~101747727&z=1704548087
Frame ID: CF8616933094BED0C056E40066C4FD3D
Requests: 1 HTTP requests in this frame

Frame: https://td.doubleclick.net/td/rul/947853199?random=1727420085394&cv=11&fst=1727420085394&fmt=3&bg=ffffff&guid=ON&async=1&gtm=45be49p0v9118141841za200&gcd=13l3l3l3l1l1&dma=0&tag_exp=101671035~101747727&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&hn=www.googleadservices.com&frm=0&tiba=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&npa=0&pscdl=noapi&auid=1741282013.1727420085&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&fledge=1&data=event%3Dgtag.config
Frame ID: 3397F414A88E7CD974913CFC892F5EC7
Requests: 1 HTTP requests in this frame

Frame: https://www.pharmasources.com/ai_service/index.html?1727420084960
Frame ID: 1209C4A9C40B8B07F026904A9CD15A44
Requests: 15 HTTP requests in this frame

Screenshot

Page Title

What companies are developing CNS drugs in China? - PharmaSources.com

Page URL History Show full URLs

  1. http://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.p... HTTP 307
    https://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.p... HTTP 302
    http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.p... HTTP 307
    https://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.p... HTTP 302
    https://www.pharmasources.com/industryinsights/76210.html HTTP 307
    http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.p... HTTP 302
    https://www.pharmasources.com/industryinsights/76210.html HTTP 302
    https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • hm\.baidu\.com/hm\.js

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • swiper(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

115
Requests

98 %
HTTPS

0 %
IPv6

8
Domains

12
Subdomains

11
IPs

4
Countries

5483 kB
Transfer

8779 kB
Size

15
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79 HTTP 307
    https://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79 HTTP 302
    http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored HTTP 307
    https://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored HTTP 302
    https://www.pharmasources.com/industryinsights/76210.html HTTP 307
    http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored HTTP 302
    https://www.pharmasources.com/industryinsights/76210.html HTTP 302
    https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

115 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request what-companies-are-developing-cns-drugs-76210.html
www.pharmasources.com/industryinsights/
Redirect Chain
  • http://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79
  • https://edm.b2b-test.com/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79
  • http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored
  • https://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored
  • https://www.pharmasources.com/industryinsights/76210.html
  • http://filter.webpower.asia/x/c/?BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79stored
  • https://www.pharmasources.com/industryinsights/76210.html
  • https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
262 KB
35 KB
Document
General
Full URL
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
84f599e8fc0516af7eb26e3ff72d7d39e62a16c94411a858b7069d8d7a525e26

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36

Response headers

Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Age
71
Cache-Control
no-cache, private no-cache
Connection
keep-alive
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Fri, 27 Sep 2024 06:54:43 GMT
Transfer-Encoding
chunked
X-Via
1.1 PShlamstdAMS1me106:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:14 (Cdn Cache Server V2.0)
x-ws-request-id
66f656b3_PS-CDG-04vDR75_48628-34216

Redirect headers

Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Cache-Control
no-cache, private no-cache
Connection
keep-alive
Content-Type
text/html; charset=UTF-8
Date
Fri, 27 Sep 2024 06:54:43 GMT
Location
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Transfer-Encoding
chunked
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:1 (Cdn Cache Server V2.0)
x-ws-request-id
66f656b2_PS-CDG-04vDR75_48628-34194
bootstrap.min.css
www.pharmasources.com/static/web/css/
125 KB
25 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/bootstrap.min.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
f74c65cc5f760ba7aa821a6e519b3f21e9c1314ab8a5d9392b7fb15aa0848a38

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_48628-34223
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:0 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-1f342"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:43 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
bootstrap-theme.min.css
www.pharmasources.com/static/web/css/
20 KB
3 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/bootstrap-theme.min.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
aa18e8fdcafd4e5da442174b99fad18c5b5e82fdcecc1f05a6054caa6283c283

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_48810-60797
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:7 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-501d"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
base.css
www.pharmasources.com/static/web/css/
18 KB
5 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/base.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
5ff32e38dc5fedf3c9775598b0abeda87eeaeb70ec5de35bd81850e677621836

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_47789-57311
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:16 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-4656"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:43 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
jquery.min.js
www.pharmasources.com/static/web/js/
91 KB
36 KB
Script
General
Full URL
https://www.pharmasources.com/static/web/js/jquery.min.js?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
89a15e9c40bc6b14809f236ee8cd3ed1ea42393c1f6ca55c7855cd779b3f922e

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_47789-57332
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:13 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-16bac"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:43 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
common.min.js
www.pharmasources.com/static/web/js/
915 B
1 KB
Script
General
Full URL
https://www.pharmasources.com/static/web/js/common.min.js?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
064626604dd1ffa5eb82206ec7e803c959cb59d95b266f7015b1359d56273b26

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_48628-34300
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:6 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-393"
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
915
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
js
www.googletagmanager.com/gtag/
214 KB
77 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=UA-164521382-1
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
e7e390c062837deb4bf89fd3cc80e86799793bb4e84ae47d81ed61f617a3083b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:44 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:44 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
last-modified
Fri, 27 Sep 2024 06:00:00 GMT
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
78501
x-xss-protection
0
server
Google Tag Manager
fonts.css
www.pharmasources.com/static/web/css/
368 B
734 B
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/fonts.css
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
5ccaff73ec0d26d06860532cf18e64caefa0647bbe470bf94d8db6e720f96548

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b3_PS-CDG-04vDR75_45540-57950
X-Via
1.1 kf29:5 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:2 (Cdn Cache Server V2.0)
ETag
"66f4d3df-170"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
368
Date
Fri, 27 Sep 2024 06:54:43 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
js
www.googletagmanager.com/gtag/
268 KB
93 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=AW-947853199
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
825a628df6fc235363f3ea51ed3540604c9f47c32bad7536d107dc22bd98693d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:44 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:44 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
last-modified
Fri, 27 Sep 2024 06:00:00 GMT
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
94748
x-xss-protection
0
server
Google Tag Manager
js
www.googletagmanager.com/gtag/
301 KB
102 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-MVK0C784Q4
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
1676ad5d843c22bd6c33d09856b854854d7e83718139c7bcaf2f0d49c8136f30
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:44 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:44 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
104537
x-xss-protection
0
server
Google Tag Manager
js
www.googletagmanager.com/gtag/
334 KB
109 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-M38VCXVV5K
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
84521ee93e7d6d5b299b27a40019a5bf36d4174c47208408c758475cc35aad7f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:44 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:44 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
111576
x-xss-protection
0
server
Google Tag Manager
index.min.css
www.pharmasources.com/static/web/css/
36 KB
9 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/index.min.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
d2c1f05f6267504ba650d9282f7118e3d45d322d461bd2c5503c4524573ec482

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_44453-78
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:8 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-8fcc"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
news.css
www.pharmasources.com/static/web/css/
23 KB
5 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/news.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
7d391bf74f667ced73386ce0543904587be83f989bb722da5c231eab10213d17

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_47789-57313
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:1 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-5a12"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
swiper.min.css
www.pharmasources.com/static/web/css/
13 KB
5 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/swiper.min.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
67e54a2ad4686f2024e769df1f2f2d4ad53011cf2d83db0eec93729f995cc516

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b3_PS-CDG-04vDR75_45540-57953
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:4 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-3563"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
swiper.min.js
www.pharmasources.com/static/web/js/
135 KB
41 KB
Script
General
Full URL
https://www.pharmasources.com/static/web/js/swiper.min.js?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3cad5361705995f61ac053ca047f4e9b02eb99832561de41809e9ffb4d671063

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57366
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:16 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-21d03"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
logo.png
www.pharmasources.com/static/web/image/images/
13 KB
13 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/logo.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ad63df51707903a1d394647eadf190002913d9207dff19e3be43a1722cf8d455

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_48810-60833
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:7 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-32b6"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
search_img.png
www.pharmasources.com/static/web/image/images/
2 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/search_img.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
777f68414302353f5460c1c7cb19a4eb8e86d3f3a2d175e7cf33691fa6b003ad

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-121
Content-Encoding
gzip
X-Via
1.1 kf29:9 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:2 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-6e4"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
0042.jpg
www.pharmasources.com/static/images/countryimg/
623 B
991 B
Image
General
Full URL
https://www.pharmasources.com/static/images/countryimg/0042.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
89fca283e4ec064b4a899fb1941e2b15e2362f01d8abafcb0bb4f04158bcd1cf

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_48628-34309
X-Via
1.1 kf29:8 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:7 (Cdn Cache Server V2.0)
ETag
"66f4d3df-26f"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
623
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/jpeg
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
img_3_03.png
www.pharmasources.com/static/web/image/images/
1 KB
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/img_3_03.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
13c123d9779aea774a28bc7163b186716896fe4620933f001ebdb5fa3b40c66d

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_45540-57998
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:18 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-578"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
E-Learn.png
www.pharmasources.com/static/web/image/images/
5 KB
4 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/E-Learn.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
e57b7f07ef3938b83da0855d702cef944ce6177302029f9d094591fc87b898fd

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-128
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:14 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-123d"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
all.png
www.pharmasources.com/static/web/image/news/
795 B
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/all.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ce466835170b384a359fd2df46eb986f5c3207dfe5de0a240e8df9ef38074b65

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-131
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:16 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-31b"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
795
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Pharma%20in%20China.png
www.pharmasources.com/static/web/image/news/
6 KB
6 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/Pharma%20in%20China.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
b7984bb1dca4649b7041e474363843410f787ebbec4611be6343df3e2ced728f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_45540-58007
Content-Encoding
gzip
X-Via
1.1 kf28:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:19 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-1798"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Pharma%20Experts.png
www.pharmasources.com/static/web/image/news/
3 KB
4 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/Pharma%20Experts.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
fab73d6d5c07f2987478d0e07c6fa92d1cecb17f796d13192e8b5127055261ed

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-135
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:6 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-c8e"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Market%20News.png
www.pharmasources.com/static/web/image/news/
2 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/Market%20News.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
baeeb8bc2df40b5c74690b6d98a8f9be31e1160cfc2d37686676ca528b22519e

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_45540-58011
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:7 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-730"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Products%20Guide.png
www.pharmasources.com/static/web/image/news/
5 KB
5 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/Products%20Guide.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
09935aef112da55e66982b2235bcaf9c4151e7b04a034fe92dda678338b5c62d

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-138
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:1 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-12d8"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Brand%20Story.png
www.pharmasources.com/static/web/image/news/
0
0

buy.png
www.pharmasources.com/static/images/
1 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/images/buy.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
b11d689feb472e5817cb91da186ef7435af9963fd997948dbd0f647ae96cfe5f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57397
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:18 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-5aa"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
FRBDaKx1FTrxLLTn9j9yk859QsT9EtLklwoCZHIC.jpg
eimg.pharmasources.com/image/20240927/
305 KB
306 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/FRBDaKx1FTrxLLTn9j9yk859QsT9EtLklwoCZHIC.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
9da68b6ffb9175be02fc1eb6a5f6164c961e68ae85a3525949c74a4e2770d9b3

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
feab84a9cd6976c7472efd0959e8933d; 0e20076afd4fca63174e19dc2d85e51e; eeaa8e0b1958efcdb781417d4f3fc930
x-upyun-content-length
312388
etag
"74ecd6e344473f4acc15cf26ccabf29f"
age
1121
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:36:06 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 06:11:31 GMT
cache-control
max-age=691200
x-source
U/200
via
T.201.M, V.403-zj-fud-206, S.pcw-cn-hkg-167, T.167.H, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
312388
server
marco/3.2
DuJ7MzHXxgueVD72teT2Kft1J1WnbQrpRT2jwGsX.jpg
eimg.pharmasources.com/image/20240927/
145 KB
145 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/DuJ7MzHXxgueVD72teT2Kft1J1WnbQrpRT2jwGsX.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
a62efc672e5fff894dd37d8e310b7897cf87348b7564506f5cab98a045aae990

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
60203ce8ea626639ea691bd6e0eaaece; 89532412df5e4c45e1d8aec73bab5304; 812710cd4bc7eb72dee47640468a9a55; a9464be7f42bb02ce76b39c0d45ee937
x-upyun-content-length
148059
etag
"03b7e2185a27c721efbbded68a2a6681"
age
2841
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:07:27 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 05:47:46 GMT
cache-control
max-age=691200
x-source
U/200
via
T.205.H, V.403-zj-fud-206, S.pcw-cn-hkg-166, T.166.H, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
148059
server
marco/3.2
qZp8gNQUJ7avAKL2ww5qZ8yl3RTTqnGhSvihNPWt.jpg
eimg.pharmasources.com/image/20240927/
16 KB
16 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/qZp8gNQUJ7avAKL2ww5qZ8yl3RTTqnGhSvihNPWt.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
2915726d53164ed9eeb2dc7a32f4b4c76412d4913604b5b7a984d10b0d0ff4ae

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
777f653706a461b96901be3f6ff95c35; cfd38c17b9fb018a871b7acc27f7f1bc; bdcd6f3ede91aa80fbadc36935d089c3
x-upyun-content-length
15946
etag
"2e837131753833fad7aee0c354d474c6"
age
8906
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 04:26:21 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 02:19:26 GMT
cache-control
max-age=691200
x-source
U/200
via
T.204.M, V.403-zj-fud-205, S.pcw-cn-hkg-165, T.165.H, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
15946
server
marco/3.2
ItB6Sc3Ru0WK2tgd6MkTHgbXJFFdIaPhSW0cPHHK.jpg
eimg.pharmasources.com/image/20240927/
153 KB
154 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/ItB6Sc3Ru0WK2tgd6MkTHgbXJFFdIaPhSW0cPHHK.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
bb1b8e60720e8142f36dd97ac8200a9e713e5abfe069caa87c3a628d9a5887c7

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
f13b9642dc694c24c85eb17cdd95e736; cf8cf303b03a71ec3ba4034a379a1021
x-upyun-content-length
156807
etag
"1b3f946ca2b582727aa3a309a92d171b"
age
17921
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 01:56:06 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 01:17:40 GMT
cache-control
max-age=691200
x-source
U/200
via
T.207.M, V.403-zj-fud-204, S.pcw-cn-hkg-163, T.163.M, V.pcw-cn-hkg-165, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
156807
server
marco/3.2
fhKhBGjNU004soM4nQjHe5O2zgzQw7OcPcqDHBqh.jpg
eimg.pharmasources.com/image/20240927/
68 KB
69 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/fhKhBGjNU004soM4nQjHe5O2zgzQw7OcPcqDHBqh.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
25574727b2165eb07a6563574995707062f4cf87c62fbc3a0dbea0ad0df49b91

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
8986ef57bfd0dc06048e8d7a25c8f946; 45d827f15af1dd37f6428d80eb0942bd; 59bb71d6722a9d161a5debf8196a390e
x-upyun-content-length
69696
etag
"0c03d68ef2509b861ca3d628a2d7322f"
age
16458
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 02:20:29 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 01:08:25 GMT
cache-control
max-age=691200
x-source
U/200
via
T.209.M, V.403-zj-fud-201, S.pcw-cn-hkg-165, T.165.H, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
69696
server
marco/3.2
hncBCz6V0rpZtsvFsP9ZQSRcfIJ4VC2Y8QxdqPML.jpg
eimg.pharmasources.com/image/20240927/
127 KB
127 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240927/hncBCz6V0rpZtsvFsP9ZQSRcfIJ4VC2Y8QxdqPML.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
cb0d007dbf991087b581b5953aa1ccb14ed1fe3de449760deacbc87e8e518d05

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
26e38ac3bb6f4e29ac2434b350ffeeaa; 8c518dc88151ae8f75c9ac81aa848c7d; fe0ab87d44db1b46054a3c2e9729c677; 1b19f2c3612a397688207a6fc8a6141b
x-upyun-content-length
129727
etag
"012ceb62bde92356de5200d55f2c147c"
age
20487
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 01:13:20 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Sep 2024 01:03:50 GMT
cache-control
max-age=691200
x-source
U/200
via
T.209.H, V.403-zj-fud-200, S.pcw-cn-hkg-164, T.164.H, V.pcw-cn-hkg-165, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
129727
server
marco/3.2
Facebook.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
475 B
846 B
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Facebook.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
fadd0e82b4162d374ae3a21ea4d60ac35328835f16667377036e57d8d5e9f321

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57404
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:0 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-1db"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
475
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Twitter.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
2 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Twitter.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3470bf4b2062803a4162e2eed64b9cf6351f0a9952639c31d2d2d402902fce16

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_48810-60880
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:3 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-61c"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1564
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Tumblr.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
724 B
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Tumblr.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ac5fa500ba37dbc3e5889d62f5eb2f91320b6b66808601a6091c2e4a7f8ef65a

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_48063-14318
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:12 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-2d4"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
724
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Pinterest.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
1 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Pinterest.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
e2c02beef5415617a57a6e760bc56f61d6c8535bb64df9c472471365e548011c

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57408
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:15 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-4a8"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
1192
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Pocket.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
944 B
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Pocket.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3f5fd8a78ed9044ec53df7da23ca4b2612cdcaba52ea194ed59950be3bfcaea9

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57403
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:6 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-3b0"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
944
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Reddit.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
7 KB
7 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Reddit.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
152d8025c46818b64f01ae855e6121710a5dde80051dd56b2e11d4ce551c1920

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-145
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:15 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-1af9"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
6905
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
LinkedIn.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
997 B
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/LinkedIn.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
88989b92c5f7183924aaa07e25caba1399941b348c60c32da373bfc2185c5783

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_48810-60878
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:6 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-3e5"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
997
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Wordpress.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
3 KB
3 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Wordpress.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
82d62e429a76db6e272abfd924769ef8ede6f97b307aa3e254e4625490e13229

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-150
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:7 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-c0c"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
3084
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Pinboard.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
442 B
814 B
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Pinboard.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
71cdbaa448a012c2e0c12a377138420c4b16f9715b5831df1a0020b93f50700f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57406
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:16 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-1ba"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
442
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Email.svg
www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/
980 B
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/social_flat_rounded_rects_svg/Email.svg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3f9f953a6a84e22b1ae5ffe1aaa1684767b9216f08484b8bfb571004aaf2e5e7

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57402
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:1 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-3d4"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
980
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/svg+xml
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
sssss.png
www.pharmasources.com/static/web/image/news/
5 KB
5 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/sssss.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
f98a5ca57d1095ba365dfab60064f01136970bb8041878d51fdef7758593af4f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57422
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:12 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-13d2"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
ct3pG37iXyDRwznliKdcnk6z5UGAXaHCZ9dA4CRm.png
eimg.pharmasources.com/image/20210806/
45 KB
45 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20210806/ct3pG37iXyDRwznliKdcnk6z5UGAXaHCZ9dA4CRm.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
55036dd6b992e53e09e2d7d439b7e36f335d7062992be2bef8fa8ae780b20d46

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
dad80fe9b0a806179941b065d63306e4; edf69ccdd11d03c95a3003687ae52e3c
x-upyun-content-length
45975
etag
"5db309296abdd6d86e04347646aac56f"
age
267138
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Wed, 02 Oct 2024 04:42:29 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/png
last-modified
Fri, 06 Aug 2021 07:53:01 GMT
cache-control
max-age=691200
x-source
U/304
via
T.164.H, V.pcw-cn-hkg-166, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/png
content-length
45975
server
marco/3.2
Mimg_1504160343727724.jpg
eimg.pharmasources.com/img_Cphi_en/Product/2015_04/
42 KB
43 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2015_04/Mimg_1504160343727724.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
149c5919a4cdeb839240e194bc589107875fa4b2c3c0a4fb69c033ee4670db70

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
b8246a8e2beaf012a6ff0ee8b7cfdd8e; 0d5c62c2210193cae6a7c45d789fe123
x-upyun-content-length
43426
etag
"5b8f032dda7c397c2f2ac90411a70ff9"
age
133
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:52:34 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Thu, 16 Apr 2015 07:43:40 GMT
cache-control
max-age=691200
x-source
U/304
via
T.167.N, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
43426
server
marco/3.2
Mimg_1408040400715218.gif
eimg.pharmasources.com/img_Cphi_en/Product/2014_08/
7 KB
8 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2014_08/Mimg_1408040400715218.gif
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
36e51fe02360956bc128f895adf790245dbf85d6ee2380babda39ba9528a0d7b

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
a112b334455744c5a63385577f31ba7b; 5c346f3def3a336c89031f553a1ad5a1
x-upyun-content-length
7321
etag
"218135caf34333880363f320c21d4599"
age
133
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:52:34 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/gif
last-modified
Mon, 04 Aug 2014 08:00:30 GMT
cache-control
max-age=691200
x-source
U/200
via
T.167.N, V.pcw-cn-hkg-164, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/gif
content-length
7321
server
marco/3.2
rOfXjbQv96yYrqnAj0DHphMYoDHDYrao2IJU4Xzi.jpeg
eimg.pharmasources.com/image/20230822/
163 KB
164 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20230822/rOfXjbQv96yYrqnAj0DHphMYoDHDYrao2IJU4Xzi.jpeg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
16d154dcffded15230f474fc8c38d1680c07cba62da3588f616153363da1e111

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
55061690e28b4fa7950d673ea3ee140a; cc186d83587440a1d01c4951661f0e2a; 40d44388e105444938a2fa469d554a63
x-upyun-content-length
167156
etag
"d8b1aaba8673bbb00797501206f3ff97"
age
235
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:50:53 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Tue, 22 Aug 2023 03:21:26 GMT
cache-control
max-age=691200
x-source
U/200
via
T.205.H, V.403-zj-fud-205, S.pcw-cn-hkg-166, T.166.H, V.pcw-cn-hkg-166, T.132.-, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
167156
server
marco/3.2
EOHjvfBn5rYsiPHVMLVkPmSRcOhZe9pE3ZflBoXG.jpeg
eimg.pharmasources.com/image/20240329/
2 MB
2 MB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240329/EOHjvfBn5rYsiPHVMLVkPmSRcOhZe9pE3ZflBoXG.jpeg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
69a58056cbe09332ac9f33777194160dff62d6badd7bc83550e683d845f24232

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

x-slice-complete-length
1810058
access-control-max-age
86400
x-request-id
fc3a5e08bf27b4bbd00368db2db31c70
x-upyun-content-length
1810058
etag
"fc1d9d16be61a84fa3be402f82b1765f"
age
234
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:50:53 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 29 Mar 2024 07:06:27 GMT
x-slice-size
1048576
cache-control
max-age=691200
x-source
U/304
via
T.165.H, V.pcw-cn-hkg-167, T.132.N, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
1810058
x-slice-etag
fc1d9d16be61a84fa3be402f82b1765f
server
marco/3.2
Mimg_1912230400480923.jpg
eimg.pharmasources.com/img_Cphi_en/Product/2019_12/
18 KB
18 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2019_12/Mimg_1912230400480923.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
a6f232a9fd43579ca278bc7e5ce4dc844856b90e3722e09a48361c915a033ee0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
7da8e6ce110b20041f91e285378caf55
x-upyun-content-length
18197
etag
"693a6f395376947cfc700dd7e7752c01"
age
234
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:50:53 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Mon, 23 Dec 2019 08:00:28 GMT
cache-control
max-age=691200
x-source
U/200
via
T.167.H, V.pcw-cn-hkg-163, T.132.N, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
18197
server
marco/3.2
Mimg_1912270258417219.jpg
eimg.pharmasources.com/img_Cphi_en/Product/2019_12/
13 KB
14 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2019_12/Mimg_1912270258417219.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
fed668e12d7b0c863eee8342ed17dca9e697ad5f62a69714b49e130c5c7eb9e0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
af4e08038dab4e774f5cf8af6488fb6f; 161ed34e262fe31bdfd05145a193b143
x-upyun-content-length
13775
etag
"180ea1c240ee7774e416ee0964aedb8a"
age
252626
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Wed, 02 Oct 2024 08:44:21 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Fri, 27 Dec 2019 06:58:44 GMT
cache-control
max-age=691200
x-source
U/304
via
T.167.H, V.pcw-cn-hkg-166, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
13775
server
marco/3.2
Mimg_1612190335317099.jpg
eimg.pharmasources.com/img_Cphi_en/Product/2016_12/
30 KB
30 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2016_12/Mimg_1612190335317099.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
419cbca10f287b237aef0b7803b1e11f0250d3f912c29fd23ec945c21b7d4d97

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
d314d728b7d5d594ab0961be5d2e8317
x-upyun-content-length
30403
etag
"e130d75f07cefb91320407810724873e"
age
74
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:53:33 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Mon, 19 Dec 2016 07:35:27 GMT
cache-control
max-age=691200
x-source
U/200
via
T.165.H, V.pcw-cn-hkg-167, T.132.N, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
30403
server
marco/3.2
OuVxOJ6PvdUMq8Vce6OJZs96TpyPWB75ufWq55Wp.jpeg
eimg.pharmasources.com/image/20210419/
71 KB
72 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20210419/OuVxOJ6PvdUMq8Vce6OJZs96TpyPWB75ufWq55Wp.jpeg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
bcd0c53cbf5edeb96e49b54d845a3b96f68ee44deaed2bd9142c5f1ded92a149

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
bf72f5558adfc08f2aadd26da3c33ebd
x-upyun-content-length
73183
etag
"01ba63eaf81f615f8eee283b9a32fdc5"
age
223
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:51:04 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Mon, 19 Apr 2021 02:29:56 GMT
cache-control
max-age=691200
x-source
U/200
via
T.166.H, V.pcw-cn-hkg-165, T.132.N, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
73183
server
marco/3.2
Mimg_1612120125790948.jpg
eimg.pharmasources.com/img_Cphi_en/Product/2016_12/
20 KB
20 KB
Image
General
Full URL
https://eimg.pharmasources.com/img_Cphi_en/Product/2016_12/Mimg_1612120125790948.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
47ac75f86d3e7245bd5fba5ac6cebb53723d5a5e31796182f4b707bec92c2bac

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
1645a56fa4e5b085c4a2bc11cd4554d0
x-upyun-content-length
20424
etag
"5f7f05ba240cebe1305f045f36191c85"
age
234
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Sat, 05 Oct 2024 06:50:53 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Mon, 12 Dec 2016 05:25:51 GMT
cache-control
max-age=691200
x-source
U/200
via
T.166.H, V.pcw-cn-hkg-164, T.132.N, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
20424
server
marco/3.2
uBbcv96xQfBho6l9lgINC1Cars9QMnt2Y51Qc9CA.jpeg
eimg.pharmasources.com/image/20201031/
60 KB
61 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20201031/uBbcv96xQfBho6l9lgINC1Cars9QMnt2Y51Qc9CA.jpeg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
7a49cba395c0b43c7e47b86e18fd567e24003d40a4380cac29efddbacd8efccb

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
80824011550660c6dffa28ea066ba424; af89356b8389a33138c54b2e16f66217
x-upyun-content-length
61658
etag
"3bb39fe2a46315f7a40d3d6b663192e1"
age
52726
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Fri, 04 Oct 2024 16:16:01 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/jpeg
last-modified
Sat, 31 Oct 2020 15:34:15 GMT
cache-control
max-age=691200
x-source
U/200
via
T.167.H, V.pcw-cn-hkg-163, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
x-upyun-content-type
image/jpeg
content-length
61658
server
marco/3.2
footer.min.css
www.pharmasources.com/static/web/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/static/web/css/footer.min.css?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
127af90f21e916729e159c17408cde31b57100e7b5c868416ce9579cb5997ab5

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_48810-60840
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:19 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-8e1"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
bn-09.png
www.pharmasources.com/static/web/image/bottomnew/
232 KB
232 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/bottomnew/bn-09.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
bf0ae120b23bc760047d0babc135f35223587caf25729d20f8c7758b25cad3a2

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57423
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:6 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-39eca"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
237258
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
follow_1.png
www.pharmasources.com/static/web/image/images/
1 KB
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/follow_1.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
9a07e7380aa40f41adcd2d7f02eef18c1639731ba366465a272601bd05b4101e

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-159
Content-Encoding
gzip
X-Via
1.1 kf29:8 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:1 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-588"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
follow_2.png
www.pharmasources.com/static/web/image/images/
1 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/follow_2.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
e94c57e355a48c4c25817aa53d5176417db86037a37be91ac777e0ac69cc5277

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57424
Content-Encoding
gzip
X-Via
1.1 kf28:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:9 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-5e3"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
follow_4.png
www.pharmasources.com/static/web/image/images/
1 KB
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/follow_4.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
d77d38583f0d315cb36c8eb03ab714ecf7abcc891d9abc586ec5639f555001a3

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-163
Content-Encoding
gzip
X-Via
1.1 kf29:8 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:10 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-575"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
22221.png
www.pharmasources.com/static/web/image/images/
2 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/22221.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
611ee68709074d9f8e85b8e0821491b3f4e89d103739648ada0f2bf38bd1194e

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57426
Content-Encoding
gzip
X-Via
1.1 kf28:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:12 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-96b"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
Z4rfTNJOwfUP7xpqzhafEXFWqljN20ATO8J2F2U9.png!145
eimg.pharmasources.com/image/20240614/
8 KB
8 KB
Image
General
Full URL
https://eimg.pharmasources.com/image/20240614/Z4rfTNJOwfUP7xpqzhafEXFWqljN20ATO8J2F2U9.png!145
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.232.59.134 Frankfurt am Main, Germany, ASN135391 (AOFEI-HK AOFEI DATA INTERNATIONAL COMPANY LIMITED, HK),
Reverse DNS
Software
marco/3.2 /
Resource Hash
ed91c0035c4657156bb915be5af5954bbfca6c5df48b6dee753c7af312ca0961

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

access-control-max-age
86400
x-request-id
5d178ad585d415c9eec0c7cbf151a9bd; 6db00b5a7c860ec97651268972199010; d3a9ecb81592fec3279e7a8b772736a0; 8107395fb689c34a6ae4ef0e97070087
etag
"f93a59ba5e2b313d1a7507a9a9522248"
age
112450
access-control-allow-methods
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
expires
Thu, 03 Oct 2024 23:40:37 GMT
date
Fri, 27 Sep 2024 06:54:47 GMT
content-type
image/png
last-modified
Fri, 14 Jun 2024 12:20:22 GMT
cache-control
max-age=691200
x-source
U/200, G/200
via
T.205.H, V.403-zj-fud-205, S.pcw-cn-hkg-166, T.166.H, V.pcw-cn-hkg-167, T.132.H, M.gtt-de-fra2-132
accept-ranges
bytes
access-control-allow-origin
*
content-length
7823
server
marco/3.2
getUserInfo.js
www.pharmasources.com/static/web/js/
4 KB
1 KB
Script
General
Full URL
https://www.pharmasources.com/static/web/js/getUserInfo.js?1727420012
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
97bd6c564281ed10dd62e2fa582cd838e3b887cf6ca40e3388954f19b8fff98d

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_48628-34312
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:1 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-e78"
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
dj.png
www.pharmasources.com/static/web/image/
580 B
959 B
Image
General
Full URL
https://www.pharmasources.com/static/web/image/dj.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
a7294e9577a19d59b43588dff29ed19a5d2002c355064c8433801b6c96171034

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57430
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:19 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-244"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
580
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
dl.png
www.pharmasources.com/static/web/image/
2 KB
3 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/dl.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
4ffc003f657009978b180aee00d62df5989f8f29f2554a99cbf693f01e7e7fd2

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-164
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:4 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-8a0"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
iconfont.css
www.pharmasources.com/module/zt/cphi/font/
695 B
1 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/module/zt/cphi/font/iconfont.css
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
c994de36d5ed7972af564e598d5b19f08d3ea50e5b4bbc32c5fdb6276a384c4e

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_45540-58002
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:17 (Cdn Cache Server V2.0)
ETag
"66f4d3de-2b7"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
695
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:14 GMT
close_ai.png
www.pharmasources.com/static/web/image/
3 KB
4 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/close_ai.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
7da97c80fc00dac92cbc28a70aeab3da0e9048ad3fcf294630eeda198019eb42

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57431
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:3 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-d19"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
ai_clicked.gif
www.pharmasources.com/static/web/image/index/
12 KB
4 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/ai_clicked.gif
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3e0fa744b8b9dcb0346e88acc33a547558dad74516f92f4c77941a0689135ea3

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57413
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:15 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-31dd"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/gif
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
whatsapp_clicked.png
www.pharmasources.com/static/web/image/index/
9 KB
10 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/whatsapp_clicked.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
9a645d945bef544fff8e82d5163b696f0ece918637b5ffcb431b544e5a6b1e29

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_48063-14322
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:5 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-24f0"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
whatsapp_detail_23.png
www.pharmasources.com/static/web/image/index/
33 KB
32 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/whatsapp_detail_23.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
f8bec26105ba7fa9069dfc3bb60970526aa343287d375d189d147794de89e07d

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57432
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:0 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-820e"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
email_clicked.png
www.pharmasources.com/static/web/image/index/
8 KB
9 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/email_clicked.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
a19a6e9e8e2ff2ffc871fd9d51885014e01e19b326fc077c0d4b54ba704fe309

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-153
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:14 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-2195"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
feedback_clicked.png
www.pharmasources.com/static/web/image/index/
9 KB
9 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/feedback_clicked.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
65f6c8caf571bb637c852702fc7c14a1ebcb26b45886fc9890c98fed8c3df4e9

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57412
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:15 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-2303"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
to_top_clicked.png
www.pharmasources.com/static/web/image/index/
8 KB
8 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/index/to_top_clicked.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
c29f335ea146b40777da8b1efcdf3c3cb6adf57f4e75284c9159c406ca98c526

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_48810-60882
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:15 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-200e"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
hm.js
hm.baidu.com/
29 KB
12 KB
Script
General
Full URL
https://hm.baidu.com/hm.js?17644c035fe7482daf90144f1ff2f247
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
111.45.3.198 , China, ASN56040 (CMNET-GUANGDONG-AP China Mobile communications corporation, CN),
Reverse DNS
Software
apache /
Resource Hash
0d2b5acd85a0b6da7fb843004296c29fe320468cc6f913b939bd4587525bea00
Security Headers
Name Value
Strict-Transport-Security max-age=172800

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

Strict-Transport-Security
max-age=172800
Cache-Control
max-age=0, must-revalidate
Content-Encoding
gzip
Etag
fee936f7056c54b1e7530c5cbea638dd
Content-Length
11348
P3p
CP="CURa ADMa DEVa PSAo PSDo OUR BUS UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
application/javascript
Server
apache
roboto.woff2
www.pharmasources.com/module/zt/investment/
254 KB
254 KB
Font
General
Full URL
https://www.pharmasources.com/module/zt/investment/roboto.woff2
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/static/web/css/fonts.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
211b465736ce7f3c0767b0a12afeab51a161e38469b24727746258bf481680d2

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer
https://www.pharmasources.com/static/web/css/fonts.css

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57379
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:6 (Cdn Cache Server V2.0)
ETag
"66f4d3de-3f854"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
260180
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
font/woff2
Last-Modified
Thu, 26 Sep 2024 03:24:14 GMT
Brand%20Story1.png
www.pharmasources.com/static/web/image/news/
4 KB
5 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/news/Brand%20Story1.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
a8aefc0f6dc3b4be15d3071d2718b2e1d90c6beb6f8d753d7cf1947a152e20da

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57400
Content-Encoding
gzip
X-Via
1.1 kf29:8 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:1 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-1161"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
search_tipe.png
www.pharmasources.com/static/web/image/images/
327 B
706 B
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/search_tipe.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
3b5ccdbb44f8116759558642f3f7c8d2ba3f89a23de37dd4ac59ac8f125b9cc2

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_48810-60875
X-Via
1.1 PS-LHR-01OgL249:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:15 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-147"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
327
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
img_4_03.png
www.pharmasources.com/static/web/image/images/
1 KB
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/img_4_03.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
c74b3b33e65943d7cef91d6bf52ee5abec9a17ad6e658c99e2d4c31b822a26fb

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-143
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01kCD210:0 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:4 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-4a5"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
news_nscr.jpg
www.pharmasources.com/static/web/image/images/
26 KB
26 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/news_nscr.jpg
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
eae449e0c059ca7b1146c488984e7ef7d54dacffabf449119879fa615bd52b2f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_47789-57401
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:6 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-66f6"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/jpeg
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
news_w.png
www.pharmasources.com/static/web/image/images/
1 KB
1 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/images/news_w.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
b199c58d01108ab6dc8895907cf87f115a71e5dd8d61a903d3f36812d0bc3b52

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_44453-139
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:4 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-4f0"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
xjt.png
www.pharmasources.com/static/m/img/
25 KB
7 KB
Image
General
Full URL
https://www.pharmasources.com/static/m/img/xjt.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
9aa8d1c8b1b035772f1970963abf1994b6d5ea2b9288b774180c9006aa0b62c1

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_44453-168
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:15 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-6465"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
p_tb2.png
www.pharmasources.com/static/web/image/pro/
2 KB
2 KB
Image
General
Full URL
https://www.pharmasources.com/static/web/image/pro/p_tb2.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/static/web/css/news.css?1727420012
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
26cdd14b3ef84cc7b873470ef9c53a47ced9d8057d3f51a207bdc9a4e78a183a

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/static/web/css/news.css?1727420012

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b4_PS-CDG-04vDR75_48628-34326
Content-Encoding
gzip
X-Via
1.1 kf28:7 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:5 (Cdn Cache Server V2.0)
ETag
W/"66f4d3e0-7d2"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
truncated
/
2 KB
2 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c239fbd2387ceff073b22f05559eb6a3a9425ccde003eccb22a998429465302f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer

Response headers

Content-Type
application/font-woff;charset=utf-8
ba.png
www.pharmasources.com/static/
19 KB
6 KB
Image
General
Full URL
https://www.pharmasources.com/static/ba.png
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
a20583c81805fe64f7fa210851ce29754af9d25fd6aa5a3225a9557529602513

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656b5_PS-CDG-04vDR75_47789-57444
Content-Encoding
gzip
X-Via
1.1 PS-LHR-01wzv245:6 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:7 (Cdn Cache Server V2.0)
ETag
W/"66f4d3df-4b38"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:15 GMT
poppinsbold.ttf
www.pharmasources.com/static/web/fonts/
150 KB
151 KB
Font
General
Full URL
https://www.pharmasources.com/static/web/fonts/poppinsbold.ttf
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
7219547ee25334cbac0fe4b3acf0bf631e48ebb622c71af038edaaa652c60875

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b4_PS-CDG-04vDR75_48628-34329
X-Via
1.1 PSdgflkfFRA1cs210:6 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:10 (Cdn Cache Server V2.0)
ETag
"66f4d3e0-25958"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
153944
Date
Fri, 27 Sep 2024 06:54:44 GMT
Content-Type
application/octet-stream
Last-Modified
Thu, 26 Sep 2024 03:24:16 GMT
getUsername
www.pharmasources.com/
0
972 B
XHR
General
Full URL
https://www.pharmasources.com/getUsername
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/static/web/js/jquery.min.js?1727420012
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Accept
*/*
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Transfer-Encoding
chunked
Cache-Control
no-cache, private, no-cache
x-ws-request-id
66f656b5_PS-CDG-04vDR75_48810-60886
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:3 (Cdn Cache Server V2.0)
Connection
keep-alive
Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
text/html; charset=UTF-8
slog
www.pharmasources.com/
721 B
1 KB
XHR
General
Full URL
https://www.pharmasources.com/slog
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/static/web/js/jquery.min.js?1727420012
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ecd0ff06e1c85106c58e19b4f3a9128754962badd44572cc67d50893072d99cf

Request headers

Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Accept
*/*
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Transfer-Encoding
chunked
Cache-Control
no-cache, private, no-cache
x-ws-request-id
66f656b5_PS-CDG-04vDR75_48063-14324
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:10 (Cdn Cache Server V2.0)
Connection
keep-alive
Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
text/html; charset=UTF-8
getUserInfo
www.pharmasources.com/
56 B
1 KB
XHR
General
Full URL
https://www.pharmasources.com/getUserInfo
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/static/web/js/jquery.min.js?1727420012
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
782a43eda47023d413965d98397f28b722ea50773829ec4f8302f1f7a4a2ed5e

Request headers

Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
X-Requested-With
XMLHttpRequest
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Accept
*/*
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Transfer-Encoding
chunked
Cache-Control
no-cache, private, no-cache
x-ws-request-id
66f656b5_PS-CDG-04vDR75_48628-34337
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:1 (Cdn Cache Server V2.0)
Connection
keep-alive
Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Date
Fri, 27 Sep 2024 06:54:45 GMT
Content-Type
text/html; charset=UTF-8
js
www.googletagmanager.com/gtag/
334 KB
109 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-M38VCXVV5K&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-164521382-1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
5f878d40065602e82c2931feb7c6ae1db59daf015876803b2d5de6637cbd9b61
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:45 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
111527
x-xss-protection
0
server
Google Tag Manager
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-164521382-1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.181.238 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s56-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
gzip
age
5077
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsgac:225:0"}],}
x-content-type-options
nosniff
expires
Fri, 27 Sep 2024 07:30:08 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 05:30:08 GMT
last-modified
Tue, 12 Dec 2023 18:09:08 GMT
content-type
text/javascript
vary
Accept-Encoding
strict-transport-security
max-age=31536000; includeSubDomains; preload
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsgac:225:0
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
20994
server
Golfe2
js
www.googletagmanager.com/gtag/
268 KB
93 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=AW-947853199&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-164521382-1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
94ab3c6eabd8e9c26544ccbc274a93ae606fe590e33cc4a13cfda0e2852504f6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:45 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
last-modified
Fri, 27 Sep 2024 06:00:00 GMT
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
94762
x-xss-protection
0
server
Google Tag Manager
js
www.googletagmanager.com/gtag/
301 KB
102 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-MVK0C784Q4&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=UA-164521382-1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.8 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s22-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
5eb10fe09b712e1b5c4fda181725c66ba9321b4200bda1010b2abc17ca23dc22
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-encoding
br
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascgcycc:838:0"}],}
expires
Fri, 27 Sep 2024 06:54:45 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
application/javascript; charset=UTF-8
vary
Accept-Encoding
access-control-allow-headers
Cache-Control
strict-transport-security
max-age=31536000; includeSubDomains
cache-control
private, max-age=900
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgcycc:838:0
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
104621
x-xss-protection
0
server
Google Tag Manager
collect
analytics.google.com/g/
0
0
Fetch
General
Full URL
https://analytics.google.com/g/collect?v=2&tid=G-MVK0C784Q4&gtm=45je49p0v893253820za200&_p=1727420084472&_gaz=1&gcd=13l3l3l3l1l1&npa=0&dma=0&tag_exp=101671035~101747727&cid=786800441.1727420085&ul=it-it&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&are=1&pae=1&frm=0&pscdl=noapi&_s=1&sid=1727420085&sct=1&seg=0&dl=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&dt=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=7903
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-MVK0C784Q4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.239.36.181 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:136:0
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsggc:136:0"}],}
expires
Fri, 01 Jan 1990 00:00:00 GMT
access-control-allow-origin
https://www.pharmasources.com
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
text/plain
server
Golfe2
collect
stats.g.doubleclick.net/g/
0
558 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-MVK0C784Q4&cid=786800441.1727420085&gtm=45je49p0v893253820za200&aip=1&dma=0&gcd=13l3l3l3l1l1&npa=0&frm=0&tag_exp=101671035~101747727
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-MVK0C784Q4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.251.168.157 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
wh-in-f157.1e100.net
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:111:0
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsggc:111:0"}],}
expires
Fri, 01 Jan 1990 00:00:00 GMT
access-control-allow-origin
https://www.pharmasources.com
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
text/plain
server
Golfe2
rul
td.doubleclick.net/td/ga/ Frame BC99
0
0
Document
General
Full URL
https://td.doubleclick.net/td/ga/rul?tid=G-MVK0C784Q4&gacid=786800441.1727420085&gtm=45je49p0v893253820za200&dma=0&gcd=13l3l3l3l1l1&npa=0&pscdl=noapi&aip=1&fledge=1&frm=0&tag_exp=101671035~101747727&z=1176663135
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-MVK0C784Q4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lhr35s10-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharmasources.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, must-revalidate
content-encoding
br
content-length
16
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Fri, 27 Sep 2024 06:54:45 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
pragma
no-cache
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
collect
analytics.google.com/g/
0
0
Fetch
General
Full URL
https://analytics.google.com/g/collect?v=2&tid=G-M38VCXVV5K&gtm=45je49p0v9128801536za200&_p=1727420084472&_gaz=1&gcd=13l3l3l3l1l1&npa=0&dma=0&tag_exp=101671035~101747727&cid=786800441.1727420085&ul=it-it&sr=1600x1200&ir=1&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&are=1&pae=1&frm=0&pscdl=noapi&_eu=EAAI&_s=1&sid=1727420085&sct=1&seg=0&dl=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&dt=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&en=page_view&_fv=1&_ss=1&tfd=8020
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-M38VCXVV5K
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.239.36.181 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:136:0
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsggc:136:0"}],}
expires
Fri, 01 Jan 1990 00:00:00 GMT
access-control-allow-origin
https://www.pharmasources.com
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
text/plain
server
Golfe2
collect
stats.g.doubleclick.net/g/
0
48 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-M38VCXVV5K&cid=786800441.1727420085&gtm=45je49p0v9128801536za200&aip=1&dma=0&gcd=13l3l3l3l1l1&npa=0&frm=0&tag_exp=101671035~101747727
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-M38VCXVV5K
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.251.168.157 Farmingdale, United States, ASN15169 (GOOGLE, US),
Reverse DNS
wh-in-f157.1e100.net
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:111:0
report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsggc:111:0"}],}
expires
Fri, 01 Jan 1990 00:00:00 GMT
access-control-allow-origin
https://www.pharmasources.com
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
content-type
text/plain
server
Golfe2
rul
td.doubleclick.net/td/ga/ Frame CF86
0
0
Document
General
Full URL
https://td.doubleclick.net/td/ga/rul?tid=G-M38VCXVV5K&gacid=786800441.1727420085&gtm=45je49p0v9128801536za200&dma=0&gcd=13l3l3l3l1l1&npa=0&pscdl=noapi&aip=1&fledge=1&frm=0&tag_exp=101671035~101747727&z=1704548087
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-M38VCXVV5K
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lhr35s10-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharmasources.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, must-revalidate
content-encoding
br
content-length
16
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Fri, 27 Sep 2024 06:54:45 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
pragma
no-cache
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
/
googleads.g.doubleclick.net/pagead/viewthroughconversion/947853199/
5 KB
3 KB
Script
General
Full URL
https://googleads.g.doubleclick.net/pagead/viewthroughconversion/947853199/?random=1727420085394&cv=11&fst=1727420085394&bg=ffffff&guid=ON&async=1&gtm=45be49p0v9118141841za200&gcd=13l3l3l3l1l1&dma=0&tag_exp=101671035~101747727&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&hn=www.googleadservices.com&frm=0&tiba=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&npa=0&pscdl=noapi&auid=1741282013.1727420085&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&fledge=1&data=event%3Dgtag.config&rfmt=3&fmt=4
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-947853199
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
cafe /
Resource Hash
4dfa6cb6c601aa8e3fc7641b41c98f880689673eaad794a96068e385d3baadb5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

cache-control
no-cache, must-revalidate
timing-allow-origin
*
content-encoding
br
pragma
no-cache
cross-origin-resource-policy
cross-origin
x-content-type-options
nosniff
expires
Fri, 01 Jan 1990 00:00:00 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
content-length
2390
date
Fri, 27 Sep 2024 06:54:45 GMT
x-xss-protection
0
content-type
text/javascript; charset=UTF-8
content-disposition
attachment; filename="f.txt"
server
cafe
947853199
td.doubleclick.net/td/rul/ Frame 3397
0
0
Document
General
Full URL
https://td.doubleclick.net/td/rul/947853199?random=1727420085394&cv=11&fst=1727420085394&fmt=3&bg=ffffff&guid=ON&async=1&gtm=45be49p0v9118141841za200&gcd=13l3l3l3l1l1&dma=0&tag_exp=101671035~101747727&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&hn=www.googleadservices.com&frm=0&tiba=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&npa=0&pscdl=noapi&auid=1741282013.1727420085&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&fledge=1&data=event%3Dgtag.config
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-947853199
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.206.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
lhr35s10-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.pharmasources.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, must-revalidate
content-encoding
br
content-length
1337
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Fri, 27 Sep 2024 06:54:45 GMT
expires
Fri, 01 Jan 1990 00:00:00 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
pragma
no-cache
server
cafe
timing-allow-origin
*
x-content-type-options
nosniff
x-xss-protection
0
collect
www.google-analytics.com/j/
1 B
423 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=1304772575&t=pageview&_s=1&dl=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&ul=it-it&de=UTF-8&dt=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YADAAUABAAAAACAAI~&jid=1045025900&gjid=227470844&cid=786800441.1727420085&tid=UA-164521382-1&_gid=1163365034.1727420086&_r=1&gtm=457e49p0za200&gcd=13l3l3l3l1l1&dma=0&tag_exp=101671035~101747727&jsscut=1&z=627577381
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.181.238 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s56-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Content-Type
text/plain
Referer
https://www.pharmasources.com/

Response headers

report-to
{"group":"coop_reporting","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/scaffolding/ascnsrsgac:175:0"}],}
x-content-type-options
nosniff
expires
Fri, 01 Jan 1990 00:00:00 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
date
Fri, 27 Sep 2024 06:54:45 GMT
last-modified
Sun, 17 May 1998 03:00:00 GMT
content-type
text/plain
cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
cross-origin-resource-policy
cross-origin
access-control-allow-credentials
true
content-security-policy-report-only
script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsgac:175:0
access-control-allow-origin
https://www.pharmasources.com
cross-origin-opener-policy-report-only
same-origin; report-to=coop_reporting
content-length
1
server
Golfe2
hm.gif
hm.baidu.com/
43 B
299 B
Image
General
Full URL
https://hm.baidu.com/hm.gif?hca=B58341C73C059458&cc=1&ck=1&cl=24-bit&ds=1600x1200&vl=1200&et=0&ja=0&ln=it-it&lo=0&rnd=223748202&si=17644c035fe7482daf90144f1ff2f247&v=1.3.2&lv=1&sn=48556&r=0&ww=1600&u=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&tt=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
111.45.3.198 , China, ASN56040 (CMNET-GUANGDONG-AP China Mobile communications corporation, CN),
Reverse DNS
Software
apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
Security Headers
Name Value
Strict-Transport-Security max-age=172800
X-Content-Type-Options nosniff

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

Strict-Transport-Security
max-age=172800
Cache-Control
private, max-age=0, no-cache
Pragma
no-cache
X-Content-Type-Options
nosniff
Content-Length
43
Date
Fri, 27 Sep 2024 06:54:46 GMT
Content-Type
image/gif
Server
apache
/
www.google.com/pagead/1p-user-list/947853199/
42 B
455 B
Image
General
Full URL
https://www.google.com/pagead/1p-user-list/947853199/?random=1727420085394&cv=11&fst=1727416800000&bg=ffffff&guid=ON&async=1&gtm=45be49p0v9118141841za200&gcd=13l3l3l3l1l1&dma=0&tag_exp=101671035~101747727&u_w=1600&u_h=1200&url=https%3A%2F%2Fwww.pharmasources.com%2Findustryinsights%2Fwhat-companies-are-developing-cns-drugs-76210.html&hn=www.googleadservices.com&frm=0&tiba=What%20companies%20are%20developing%20CNS%20drugs%20in%20China%3F%20-%20PharmaSources.com&npa=0&pscdl=noapi&auid=1741282013.1727420085&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&fledge=1&data=event%3Dgtag.config&rfmt=3&fmt=3&is_vtc=1&cid=CAQSGwDpaXnfm_dC-K0vXI5xbqCkOiaGBmBtKaw2bQ&random=3272837065&rmt_tld=0&ipr=y
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.100 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s49-in-f4.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Content-Security-Policy script-src 'none'; object-src 'none'
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/

Response headers

content-security-policy
script-src 'none'; object-src 'none'
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
pragma
no-cache
cross-origin-resource-policy
cross-origin
x-content-type-options
nosniff
expires
Fri, 01 Jan 1990 00:00:00 GMT
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
content-length
42
date
Fri, 27 Sep 2024 06:54:46 GMT
x-xss-protection
0
content-type
image/gif
server
cafe
favicon.ico
www.pharmasources.com/img/
4 KB
5 KB
Other
General
Full URL
https://www.pharmasources.com/img/favicon.ico
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
974f2b640f95d4d6d5a1ae31b62774c9371d3edba43edcd076797059862862bc

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html

Response headers

x-ws-request-id
66f656b8_PS-CDG-04vDR75_48628-34507
X-Via
1.1 kf28:5 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:19 (Cdn Cache Server V2.0)
ETag
"66f4d3dd-10be"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
4286
Date
Fri, 27 Sep 2024 06:54:48 GMT
Content-Type
image/x-icon
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
index.html
www.pharmasources.com/ai_service/ Frame 1209
371 B
759 B
Document
General
Full URL
https://www.pharmasources.com/ai_service/index.html?1727420084960
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
1614f6997613eeea2dd8f703146f19c6c9e5091c2be78414f9ab13d18f76b529

Request headers

Referer
https://www.pharmasources.com/industryinsights/what-companies-are-developing-cns-drugs-76210.html
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36

Response headers

Accept-Ranges
bytes
Connection
keep-alive
Content-Length
371
Content-Type
text/html; charset=utf8
Date
Fri, 27 Sep 2024 06:54:50 GMT
ETag
"66f4d3dd-173"
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:18 (Cdn Cache Server V2.0)
x-ws-request-id
66f656ba_PS-CDG-04vDR75_48628-34563
index1724308780629.js
www.pharmasources.com/ai_service/assets/ Frame 1209
2 MB
523 KB
Script
General
Full URL
https://www.pharmasources.com/ai_service/assets/index1724308780629.js
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/index.html?1727420084960
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
29c684b7ddbc7382479bdc635b7357dda33752794e6ed4461b4032ed0a440845

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656ba_PS-CDG-04vDR75_48628-34584
Content-Encoding
gzip
X-Via
1.1 kf29:7 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:12 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-1a477b"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:50 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
truncated
/ Frame 1209
37 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
bb229a48bee31f5d54ca12dc9bd960c63a671f0d4be86a054c1d324a44499d96

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer

Response headers

Content-Type
image/gif
home1724308780629.js
www.pharmasources.com/ai_service/assets/ Frame 1209
253 KB
91 KB
Script
General
Full URL
https://www.pharmasources.com/ai_service/assets/home1724308780629.js
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/assets/index1724308780629.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
00763b9233db6eb8a6c112489f141cba8e0de732284275ab74fd22116d366f99

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656bb_PS-CDG-04vDR75_48628-34611
Content-Encoding
gzip
X-Via
1.1 kf29:7 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:6 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-3f282"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
application/javascript; charset=utf8
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
home1724308780629.css
www.pharmasources.com/ai_service/assets/ Frame 1209
3 KB
1 KB
Stylesheet
General
Full URL
https://www.pharmasources.com/ai_service/assets/home1724308780629.css
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/assets/index1724308780629.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
04c27f201e4e60daa44ff68a595703a9c5c99c3dd9529dfcdf6fe51c50308df5

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656bb_PS-CDG-04vDR75_48810-61168
Content-Encoding
gzip
X-Via
1.1 kf29:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:7 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-bdf"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
text/css
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
poppins1724308780629.ttf
www.pharmasources.com/ai_service/assets/ Frame 1209
41 KB
41 KB
Font
General
Full URL
https://www.pharmasources.com/ai_service/assets/poppins1724308780629.ttf
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/assets/home1724308780629.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
46d2af61ffe7869e04beca160875f3cb569f35c37c03ed53f4a998c5c99250d7

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Origin
https://www.pharmasources.com
Referer
https://www.pharmasources.com/ai_service/assets/home1724308780629.css

Response headers

x-ws-request-id
66f656bb_PS-CDG-04vDR75_47789-57686
X-Via
1.1 kf28:1 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:16 (Cdn Cache Server V2.0)
ETag
"66f4d3dd-a378"
Age
1
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
41848
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
application/octet-stream
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
banner1724308780629.png
www.pharmasources.com/ai_service/assets/ Frame 1209
7 KB
7 KB
Image
General
Full URL
https://www.pharmasources.com/ai_service/assets/banner1724308780629.png
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
db2caa5fd81c907ea7dca6eb05e334ea6aaf4fe78355e7a52964e59ec7048b3c

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656bb_PS-CDG-04vDR75_48628-34619
Content-Encoding
gzip
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:10 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-1b8e"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
ai_tx1724308780629.png
www.pharmasources.com/ai_service/assets/ Frame 1209
6 KB
6 KB
Image
General
Full URL
https://www.pharmasources.com/ai_service/assets/ai_tx1724308780629.png
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ae00e1c5a283102751407d7cbfa0aedbd33f5c9edc4a1177a789ae73503f6a53

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

Transfer-Encoding
chunked
x-ws-request-id
66f656bb_PS-CDG-04vDR75_48810-61173
Content-Encoding
gzip
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:0 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-1709"
Age
1
Connection
keep-alive
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
truncated
/ Frame 1209
3 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8d85d8a735c318db9f2c691858312705e733cfb1b53e8ec3b096bb725d12b15f

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer

Response headers

Content-Type
image/png
truncated
/ Frame 1209
4 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1615980c60805ef0b00a590dfb674cc47b54faa9394008f8d0d0cb0492e71aec

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer

Response headers

Content-Type
image/png
history
www.pharmasources.com/Ai/ Frame 1209
88 B
1 KB
XHR
General
Full URL
https://www.pharmasources.com/Ai/history
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/assets/index1724308780629.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
2b9ff8d194c1e9acc893e73b7400de941bc67cbcb53adf6957b7cc4de981d66c

Request headers

Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960
User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Accept
application/json, text/plain, */*
Content-Type
application/json

Response headers

Transfer-Encoding
chunked
Cache-Control
no-cache, private, no-cache
x-ws-request-id
66f656bb_PS-CDG-04vDR75_48063-14637
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-04vDR75:1 (Cdn Cache Server V2.0)
Connection
keep-alive
Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
text/html; charset=UTF-8
userInfo
www.pharmasources.com/Ai/ Frame 1209
88 B
1 KB
XHR
General
Full URL
https://www.pharmasources.com/Ai/userInfo
Requested by
Host: www.pharmasources.com
URL: https://www.pharmasources.com/ai_service/assets/index1724308780629.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
2b9ff8d194c1e9acc893e73b7400de941bc67cbcb53adf6957b7cc4de981d66c

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Accept
application/json, text/plain, */*
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

Transfer-Encoding
chunked
Cache-Control
no-cache, private, no-cache
x-ws-request-id
66f656bb_PS-CDG-04vDR75_47789-57685
Content-Encoding
gzip
X-Via
1.1 PShlamstdAMS1gl107:2 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:4 (Cdn Cache Server V2.0)
Connection
keep-alive
Access-Control-Allow-Methods
GET, POST, OPTIONS
Access-Control-Allow-Origin
*
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
text/html; charset=UTF-8
example
www.pharmasources.com/Ai/ Frame 1209
0
0

banner1724308780629.png
www.pharmasources.com/ai_service/assets/ Frame 1209
7 KB
0
Image
General
Full URL
https://www.pharmasources.com/ai_service/assets/banner1724308780629.png
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
db2caa5fd81c907ea7dca6eb05e334ea6aaf4fe78355e7a52964e59ec7048b3c

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

x-ws-request-id
66f656bb_PS-CDG-04vDR75_48628-34619
Content-Encoding
gzip
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-044e582:10 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-1b8e"
Age
1
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT
ai_tx1724308780629.png
www.pharmasources.com/ai_service/assets/ Frame 1209
6 KB
0
Image
General
Full URL
https://www.pharmasources.com/ai_service/assets/ai_tx1724308780629.png
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
157.185.128.14 Paris, France, ASN54994 (ML-1432-54994, CA),
Reverse DNS
Software
/
Resource Hash
ae00e1c5a283102751407d7cbfa0aedbd33f5c9edc4a1177a789ae73503f6a53

Request headers

User-Agent
Mozilla/5.0 (X11; Linux x86_64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/129.0.0.0 Safari/537.36
Referer
https://www.pharmasources.com/ai_service/index.html?1727420084960

Response headers

x-ws-request-id
66f656bb_PS-CDG-04vDR75_48810-61173
Content-Encoding
gzip
X-Via
1.1 kf29:10 (Cdn Cache Server V2.0), 1.1 PS-CDG-04m3O77:0 (Cdn Cache Server V2.0)
ETag
W/"66f4d3dd-1709"
Age
1
Date
Fri, 27 Sep 2024 06:54:51 GMT
Content-Type
image/png
Last-Modified
Thu, 26 Sep 2024 03:24:13 GMT

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
www.pharmasources.com
URL
https://www.pharmasources.com/static/web/image/news/Brand%20Story.png
Domain
www.pharmasources.com
URL
https://www.pharmasources.com/Ai/example

Verdicts & Comments Add Verdict or Comment

49 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 function| $ function| jQuery object| common function| gtag object| dataLayer object| _hmt function| getCookieNew function| Swiper string| type function| getSearchData function| phs object| searchList function| searchKeyup function| searchIcon function| removePage boolean| jump_ws boolean| jump_ws_t number| timestamp string| urlWithTimestamp function| closePopup function| getSearchKey function| getIsMobile string| login_show string| is_login function| reds function| reds2 function| reds3 number| favNum boolean| jump number| download_login function| download object| swiper3 function| cfc string| is_on object| jQuery1102006087813256935948 object| google_tag_manager object| google_tag_data string| GoogleAnalyticsObject function| ga function| onYouTubeIframeAPIReady object| gaGlobal object| GooglebQhCsO object| gaplugins object| gaData boolean| _bdhm_loaded_17644c035fe7482daf90144f1ff2f247

15 Cookies

Domain/Path Name / Value
.filter.webpower.asia/ Name: DMDconv
Value: BcFLDoMgEADQq.QEfKxAbTI7tz2EQeMQAQ0zhvT043sR7CQFwttIg9GZyYVRMrjgBQGZL.pq3XtXFy6tLHTeLW6k4ll0qutN3P6pUtqRSQc.WKOQS5YV5t_cUz1ew_cBA79
www.pharmasources.com/ Name: acw_tc
Value: 0a47315217274200827623674e00452bd00eb700fdffc4bc1d97dd98d4e42a
www.pharmasources.com/ Name: chatWindowOpened
Value: true
.pharmasources.com/ Name: _ga_MVK0C784Q4
Value: GS1.1.1727420085.1.0.1727420085.60.0.0
.pharmasources.com/ Name: _ga_M38VCXVV5K
Value: GS1.1.1727420085.1.0.1727420085.60.0.0
.pharmasources.com/ Name: _gcl_au
Value: 1.1.1741282013.1727420085
.pharmasources.com/ Name: _ga
Value: GA1.2.786800441.1727420085
.pharmasources.com/ Name: _gid
Value: GA1.2.1163365034.1727420086
.pharmasources.com/ Name: _gat_gtag_UA_164521382_1
Value: 1
.doubleclick.net/ Name: test_cookie
Value: CheckForPermission
.hm.baidu.com/ Name: HMACCOUNT_BFESS
Value: B58341C73C059458
.pharmasources.com/ Name: Hm_lvt_17644c035fe7482daf90144f1ff2f247
Value: 1727420086
.pharmasources.com/ Name: Hm_lpvt_17644c035fe7482daf90144f1ff2f247
Value: 1727420086
.pharmasources.com/ Name: HMACCOUNT
Value: B58341C73C059458
.pharmasources.com/ Name: laravel_session
Value: eyJpdiI6IjdsZ09QNUtuc1BQc0RXTXo2SXRTR0E9PSIsInZhbHVlIjoiQ0UyZ1JRV2crc3JLZlR6WXowY0hJWi9BZHNuWWx4Z2ZSMVhVMWlGVlRMM0xtMmJFeEE0eThweWVVTWlpTUpCaXBObE9QeldiQVNLa1B2Q0RTRVhxZWREZTBDNGNJb1pHSDE5dzFLcEhKMEI0VzZibXVMRkFJMFFDNDU5eDRyL3EiLCJtYWMiOiIyZDQ3NThhYjE3ODZkYzU5ZWI1ZDgzOTBhOTk5Y2RjMWE5YWJkYTk0NWYyYjU1YmQ4Y2JlYTNhODAwMWVjMmY0IiwidGFnIjoiIn0%3D

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

analytics.google.com
edm.b2b-test.com
eimg.pharmasources.com
filter.webpower.asia
googleads.g.doubleclick.net
hm.baidu.com
stats.g.doubleclick.net
td.doubleclick.net
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.pharmasources.com
www.pharmasources.com
111.45.3.198
142.250.181.238
142.250.185.100
142.250.186.98
142.251.168.157
157.185.128.14
172.217.18.8
185.232.59.134
216.239.36.181
216.58.206.34
61.147.84.35
61.147.84.43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